Clinical trial
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
NCT00446329 · Papageorgiou General Hospital, Other · Terminated
Key facts
| NCT number | NCT00446329 |
|---|---|
| Title | Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis |
| Lead sponsor | Papageorgiou General Hospital, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | cinacalcet |
| Enrollment | 15 |
| Start date | Jul 1, 2006 |
| First posted | Mar 12, 2007 |
| Last update posted | Oct 29, 2014 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: